Robert W. Duggan - Co-Chief Executive Officer, Director, 10%+ Owner at Summit Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Co-Chief Executive Officer, Director, 10%+ Owner
Stock Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert W. Duggan since 12/3/2023

Holdings reported by Robert W. Duggan for Summit Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 552M $12.5B $22.70 Sep 11, 2024 Direct
Stock Option (right to buy) 74.5K $98.4K $1.32 Jan 2, 2024 Direct Common Stock

Transactions reported by Robert W. Duggan for Summit Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.